A2-73 crystalline polymorph compositions of matter and methods of use thereof
AssigneeAnavex Life Sciences Corp.
InventorsChristopher U. MISSLING, Alani SELVEY
Life of this patent
Estimating the term…
Abstract
The present disclosure provides crystalline forms of tetrahydro-N,N-dimethyl-2,2-diphenyl-3-furanmethanamine (A2-73), in freebase or salt forms. Also described are pharmaceutical formulations and dosage forms comprising the disclosed crystal forms, and methods of using crystalline A2-73 in dosage forms for neuroprotection including treatment of neurodegenerative and other diseases.
Claims20
A crystalline form of tetrahydro-N,N-dimethyl-2,2-diphenyl-3-furanmethanamine (A2-73), wherein the crystalline form is a A2-73 salt selected from the group consisting of a hydrochloride salt, a sulfate salt, a dihydrogen phosphate salt, a benzoate salt, a mesylate salt, an edisylate salt, and an oxalate salt.
Dependencies are inferred from the claim text.